Tampa General Hospital appoints Dr. Usha Menon to drive community cancer care and advance NCI-designation goals

Tampa General Hospital (TGH) Cancer Institute has appointed Usha Menon, Ph.D., RN, FAAN, FSBM, as associate director of community outreach and engagement, a move that underscores the hospital’s push to strengthen its academic-community partnerships and position itself for a National Cancer Institute (NCI) designation within the decade. Menon, who will continue in her capacity as dean and distinguished university health professor at the University of South Florida (USF) College of Nursing and senior associate vice president at USF Health, is widely recognized for her expertise in behavioral science, cancer prevention, and culturally tailored interventions for underserved populations.

This dual role cements the strategic alignment between TGH and USF Health, two institutions working to transform cancer care delivery, enhance research output, and expand access to evidence-based treatment across Florida. In the competitive U.S. cancer institute landscape, NCI designation is a sought-after status that can boost patient referrals, secure substantial federal research funding, and attract top-tier faculty. Tampa General’s latest leadership move reflects the broader national trend of academic medical centers deepening community engagement to meet both scientific and public health benchmarks required for such recognition.

Why Tampa General is investing in community-centered cancer care

Menon’s appointment comes at a time when cancer care providers are increasingly judged not only on their clinical outcomes, but also on their ability to reach historically underserved and rural populations. According to the American Cancer Society, disparities in cancer incidence and mortality persist along racial, socioeconomic, and geographic lines, with preventive screening rates significantly lower among rural residents and certain minority groups. TGH Cancer Institute aims to close these gaps by leveraging Menon’s decades-long experience designing and implementing interventions that address cultural, literacy, and access barriers.

Vice president and director of the TGH Cancer Institute, Dr. Eduardo M. Sotomayor, emphasized that this leadership addition is central to the hospital’s mission to broaden its reach. He noted that Menon’s work will enable TGH to extend oncology services to rural areas across Florida, strengthen partnerships with community organizations, and build a more robust pipeline for patient engagement in both clinical care and research trials.

Linking leadership to broader academic and healthcare trends

Tampa General’s strategy aligns with national efforts to integrate academic research into real-world settings through community-engaged approaches. This trend is particularly visible among cancer centers seeking NCI status, which increasingly requires demonstrable impact on local cancer burdens. The hospital’s alliance with USF Health provides the academic infrastructure to support these ambitions — from access to research faculty to the ability to launch multi-disciplinary programs that span clinical oncology, behavioral medicine, and public health.

Dr. Charles J. Lockwood, executive vice president of USF Health and dean of the Morsani College of Medicine, highlighted that Menon’s expanded role will harness interprofessional collaboration to improve complex health outcomes. Lockwood, who also serves as executive vice president and chief academic officer at TGH, positioned this appointment as a natural extension of the joint TGH–USF commitment to delivering high-quality, academically informed care to Florida residents.

Track record in innovation and workforce development

Menon’s career spans over 25 years and is rooted in frameworks such as the Health Belief Model and the ConNECT Framework, both of which she has applied across diverse populations experiencing high cancer burdens. Her recent projects include leading a four-year, Health Resources and Services Administration (HRSA)-funded initiative operating the Mo-Bull Nurse Medical Clinic, a mobile primary care service targeting underserved Tampa Bay neighborhoods. This initiative also trains nursing students in community-based care delivery, directly addressing Florida’s persistent nursing shortage.

Her leadership in securing a $40 million legislative award for nursing education expansion at the USF College of Nursing underscores her influence in shaping the state’s healthcare workforce. Under her tenure, the college achieved top rankings in Florida for its Bachelor of Science in Nursing, Master of Science in Nursing, and Doctor of Nursing Practice programs, a credential that strengthens TGH’s recruitment capabilities for highly trained nursing talent.

Advancing access through mobile and specialty care initiatives

Beyond nursing education, Menon has pioneered models for bringing healthcare directly to those least likely to access it. The Mo-Bull Nurse Medical Clinic and the Port of Tampa Seafarers Center Clinic both deliver interprofessional care outside traditional hospital settings. Such initiatives align closely with Tampa General’s community outreach priorities, as they can serve as entry points for preventive cancer screening, patient education, and clinical trial enrollment.

Her work also complements Tampa General’s status as one of the few Florida cancer centers backed by academic medicine, a positioning that offers a competitive advantage in adopting advanced diagnostics, implementing novel therapeutics, and participating in cutting-edge multi-center research studies.

Recognition and prior national leadership roles

Menon is a fellow of both the American Academy of Nursing and the Society for Behavioral Medicine, reflecting her dual contributions to clinical practice and research innovation. Her publication record spans cancer prevention, culturally sensitive health interventions, health literacy, and implementation science. She has served as a multiple principal investigator for the National Institutes of Health’s All of Us Precision Medicine Initiative and has led National Cancer Institute-funded research to increase colorectal cancer screening among underserved groups.

TGH oncology leadership, including Dr. Abraham Schwarzberg, executive vice president and chief of oncology, underscored that Menon’s ability to unite stakeholders across disciplines will be instrumental in elevating Tampa General’s clinical and translational research output.

Competitive positioning in the U.S. cancer care market

The TGH Cancer Institute currently ranks among the top 10% of cancer centers nationwide according to U.S. News & World Report’s 2025–2026 Best Hospitals rankings. It also holds accreditation from the American College of Surgeons Commission on Cancer and certification from the American Society of Clinical Oncology’s Quality Oncology Practice Initiative (QOPI). These credentials signal adherence to rigorous standards in patient care, safety, and continuous quality improvement.

Newsweek has named it among America’s Best Cancer Hospitals, a recognition that enhances its appeal to patients seeking comprehensive, multidisciplinary oncology services. Such rankings can also influence philanthropic donations and institutional partnerships, key resources for sustaining growth in research and outreach programs.

Market and institutional sentiment

While not publicly traded, Tampa General operates in a competitive healthcare market where hospital reputation and service line differentiation drive patient volumes and payer negotiations. Menon’s appointment has been well-received by stakeholders familiar with her track record, suggesting internal confidence that her leadership will translate into measurable improvements in outreach metrics, screening rates, and patient satisfaction scores. The broader Florida healthcare community, particularly in academic medicine, views this as a model of how leadership appointments can bridge the gap between hospital-based innovation and community-level impact.

Next steps toward NCI designation

Achieving NCI designation will require Tampa General to demonstrate sustained excellence in research, patient care, and community engagement. This typically involves expanding clinical trial portfolios, publishing impactful research, and showing measurable reductions in cancer disparities within the service area. Menon’s portfolio at TGH will likely integrate these objectives, aligning academic resources with patient needs through targeted screening initiatives, culturally informed patient navigation programs, and partnerships with local health departments and nonprofit organizations.

Healthcare analysts note that NCI-designated centers often experience a surge in research grant funding and patient referrals, both of which can drive long-term institutional growth. Given the momentum from recent program expansions and high national rankings, Tampa General appears poised to make significant progress toward this goal in the coming years.